Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jane Reusch

Endocrinology, Diabetes & Metabolism Aurora, CO Medical Doctor

NPI 1487673000 CMS profile 340262

12605 E 16Th Ave, Aurora, CO 80045

Open in the dashboard

General payments

$58,682

84 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,500 paid to institutions, not to them · program years 2020–2021

Through program year 2025, Jane Reusch of Aurora, CO is reported in the CMS Open Payments database as having received $58,682 across 84 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $1,500 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 91st percentile of Endocrinology, Diabetes & Metabolism profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,265 2
2024 General $7,375 11
2023 General $7,817 19
2022 General $12,922 19
2021 General $8,934 14
2020 General $4,050 2
2019 General $16,320 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jane Reusch
  • Endocrinology, Diabetes & Metabolism median
  • Middle half of Endocrinology, Diabetes & Metabolism
  • National median

In program year 2025, general payments to Jane Reusch were reported at $1,265. Among 5,868 Endocrinology, Diabetes & Metabolism profiles paid that year, the median was $507 and the middle half received between $135 and $1,838.

Show as a table
Year Jane Reusch Endocrinology, Diabetes & Metabolism median Middle half National median
2019 $16,320 $494 $123–$2,253 $163
2020 $4,050 $335 $85–$1,841 $114
2021 $8,934 $398 $88–$1,981 $132
2022 $12,922 $364 $88–$1,568 $149
2023 $7,817 $420 $113–$1,614 $160
2024 $7,375 $440 $121–$1,646 $164
2025 $1,265 $507 $135–$1,838 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $38,059 61 payments
  2. Medtronic MiniMed, Inc. $11,591 11 payments
  3. Sanofi-Aventis U.S. LLC $8,779 8 payments
  4. Esperion Therapeutics, Inc. $131 1 payment
  5. Novo Nordisk Inc $122 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $41,957 7 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $10,688 3 payments
  3. Travel and Lodging $4,145 38 payments
  4. Food and Beverage $1,860 35 payments
  5. Education $32 1 payment
Products named General payments · program years 2019–2025
  1. SOLIQUA 100/33 $8,779 8 payments
  2. MINIMED 780G $2,703 19 payments
  3. MINIMED 770G $1,279 14 payments
  4. Minimed 670G System $960 7 payments
  5. Minimed 770G System $683 11 payments
  6. NEXLETOL $131 1 payment
  7. NEXLIZET $131 1 payment
  8. Ozempic $63 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

84 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Endocrinology, Diabetes & Metabolism in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record